Barriers to routine G6PD testing prior to treatment with primaquine

BACKGROUND: Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency are now av...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Ley, Benedikt, Thriemer, Kamala, Jaswal, Jessica, Poirot, Eugenie, Alam, Mohammad Shafiul, Phru, Ching Swe, Khan, Wasif Ali, Dysoley, Lek, Qi, Gao, Kheong, Chong Chee, Shamsudin, Ummi Kalthom, Chen, Ingrid, Hwang, Jimee, Gosling, Roly, Price, Ric N.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553859/
https://ncbi.nlm.nih.gov/pubmed/28797255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-017-1981-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados